Detalles de la búsqueda
1.
Evaluation of European LeukemiaNet 2022 risk classification in patients undergoing allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia: Identification of a very poor prognosis genetic group.
Br J Haematol
; 2024 May 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38811025
2.
A low total metabolic tumor volume independently predicts for a longer time to first treatment in initially observed, low tumor burden follicular lymphoma.
Hematol Oncol
; 42(1): e3235, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37942762
3.
New Cases and Mutations in SEC23B Gene Causing Congenital Dyserythropoietic Anemia Type II.
Int J Mol Sci
; 24(12)2023 Jun 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37373084
4.
Successful management of three patients with autoimmune thrombotic thrombocytopenic purpura with paradigm-changing therapy: Caplacizumab, steroids, plasma exchange, rituximab, and intravenous immunoglobulins (CASPERI).
Transfus Apher Sci
; 60(1): 103011, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33221124
5.
Acquired erythropoietic uroporphyria secondary to myeloid malignancy: A case report and literature review.
Photodermatol Photoimmunol Photomed
; 38(1): 86-91, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34319628
6.
Infrequent Presentations of Chronic NPM1-Mutated Myeloid Neoplasms: Clinicopathological Features of Eight Cases from a Single Institution and Review of the Literature.
Cancers (Basel)
; 16(4)2024 Feb 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38398096
7.
Incidence, risk factors, and impact of early cardiac toxicity after allogeneic hematopoietic cell transplant.
Blood Adv
; 7(10): 2018-2031, 2023 05 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-36453637
8.
A novel ETV6::FGFR1 fusion gene in a myeloid/lymphoid neoplasm with FGFR1 rearrangement sensitive to specific FGFR1-2-3 inhibition.
Leuk Lymphoma
; 65(3): 394-398, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38117930
9.
Venetoclax with hypomethylating agents might lead to eradication of measurable residual disease (MRD) persisting after intensive chemotherapy in acute myeloid leukemia (AML) patients with mutated NPM1 and rearranged CBF.
Leuk Res
; 135: 107403, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37837718
Resultados
1 -
9
de 9
1
Próxima >
>>